Previous studies reported that TNFAIP8 is highly expressed in the infiltrating CD4+/CD8+ T cells of patients with thyroid cancer36, suggesting that it might be involved in the occurrence and progression of HNC via the modulation of tumour immune status. The gene discussed is CD8A; the disease is neoplasm.